drug-therapy

Documents about drug-therapy

• Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.#338520NCBI PubMed Central
• Dynamic phenotype monitoring to prevent genotype-phenotype discrepancies in pharmacogenetic-guided drug therapy.#378509NCBI PubMed Central
• Efficacy of Ramelteon in Adults With Chronic Insomnia#827434ClinicalTrials.gov
• A Study of MLN0264 in Patients With Pancreatic Cancer#862903ClinicalTrials.gov
• A Study on Vonoprazan in the Real-world Clinical Practice in China#902322ClinicalTrials.gov
• A Study of Different Forms of TAK-994 in Healthy Adults#1010914ClinicalTrials.gov
• Low soluble drug encapsulation based on architecture of layer-by-layer assembly for longer circulation time and targeted therapy#957858Louisiana Tech Digital Commons
• A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA#802118ClinicalTrials.gov
• HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia#914430ClinicalTrials.gov
• Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients#811365ClinicalTrials.gov
• Dietary Therapy In Epilepsy Treatment (DIET-Trial): A Randomised Non Inferiority Trial Comparing KD, MAD & LGIT for Drug Resistant Epilepsy#846597ClinicalTrials.gov
• Comprehensive Medication Monitoring on Heart Failure Patient Outcomes#864152ClinicalTrials.gov
• Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -#875066ClinicalTrials.gov
• Factors of Potentially Dangerous Drug Interactions in Patients With Cardiovascular Diseases and Multimorbidity#968129ClinicalTrials.gov
• TIL and Anti-PD1 in Metastatic Melanoma#1009054ClinicalTrials.gov
• A Safety Study of SGN-CD33A in AML Patients#1032401ClinicalTrials.gov
• Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment#911008ClinicalTrials.gov
• Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes#181721ClinicalTrials.gov
• Cardiometabolic Health of Children Exposed to Anti-retroviral Therapy (ART) in Utero#640476ClinicalTrials.gov
• A dual action coumarin-camptothecin polymer for light responsive drug release and photodynamic therapy#684931HAL (France)
• A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation#801432ClinicalTrials.gov
• Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study#832299ClinicalTrials.gov
• Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"#840059ClinicalTrials.gov
• A Study of TAK-861 in People With Narcolepsy Type 1#843948ClinicalTrials.gov
• A Study of TAK-994 in Adults With Narcolepsy#850713ClinicalTrials.gov
• TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability Study#859411ClinicalTrials.gov
• Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"#887117ClinicalTrials.gov
• Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids#906730ClinicalTrials.gov
• Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants#909909ClinicalTrials.gov
• Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia#912509ClinicalTrials.gov
• UPLC-MS/MS Monitoring of Emicizumab Therapy#979459ClinicalTrials.gov
• Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib#1009664ClinicalTrials.gov
• Tezepelumab's Effects on Patient-Reported Symptoms in Severe Asthma, Overall and With History of Comorbid Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)#305445ODU Digital Commons
• 1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease#880432ClinicalTrials.gov
• Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)#835369ClinicalTrials.gov
• Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis#800791ClinicalTrials.gov
• "Extended" (Alternate Day) Antipsychotic Dosing#995303ClinicalTrials.gov
• Comparison of Intravascular Ultrasound-Guided vs. Angiography-guided Angioplasty and Dual-antiplatelet v. Triple-antiplatelet Therapy for Outcomes of Drug-coated Balloon in the Treatment of Femoropopliteal Artery Disease (IVUS-DCB)#903653ClinicalTrials.gov
• A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China#913358ClinicalTrials.gov
• Targeted drug delivery systems for cardiovascular disease treatment: principles, targeting strategies, and future prospects#253504Europe PMC
• Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs#660643WHO IRIS
• A Study to Compare Two Anti-HIV Drug Combinations#915018ClinicalTrials.gov
• Exosome-Inspired Nanocarriers in Cancer Therapy: Bio-Derived Nanotechnology Meets Nano Drug Delivery.#422913NCBI PubMed Central
• Efficacy and Safety of TAK-653 in Treatment-Resistant Depression#827862ClinicalTrials.gov
• Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease#835325ClinicalTrials.gov
• Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia#851301ClinicalTrials.gov
• Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis#854343ClinicalTrials.gov
• A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan#856907ClinicalTrials.gov
• A Study of CDPATH™ to Help Manage and Treat Crohn's Disease#880687ClinicalTrials.gov
• A Study of TAK-861 for the Treatment of Narcolepsy Type 1#889357ClinicalTrials.gov